🔎 Trials Near Me

Pradžia › Kraujos sutrikimai › Ohio

Kraujos sutrikimai klinikiniai tyrimai Ohio

6 tyrimai dėl Kraujos sutrikimai ieško dalyvių vietose Ohio.

Miestai Ohio

Oficialus tyrimo tekstas (anglų kalba)

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 8, Columbus
Renkami dalyviai3 fazė
Amžius nuo 18 iki 71 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07504458

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Cleveland Clinic, Cleveland
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Cleveland Clinic, Cleveland
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06948318

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Akron Children's Hospital - Showers Center for Cancer & Blood Disorders, Akron
  • Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati
  • University of Cincinnati Medical Center Hemophilia Treatment Center, Cincinnati
  • ir dar 5
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-30 · NCT04256317

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

  • University of Cincinnati, Cincinnati
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-11-15 · NCT06034275

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.